Efficacy and safety of intravenous laronidase for mucopolysaccharidosis type I: A systematic review and meta-analysis.

MLA

Dornelles, Alícia Dorneles, et al. “Efficacy and Safety of Intravenous Laronidase for Mucopolysaccharidosis Type I: A Systematic Review and Meta-Analysis.” PLoS ONE, vol. 12, no. 8, Aug. 2017, pp. 1–18. EBSCOhost, https://doi.org/10.1371/journal.pone.0184065.

APA

Dornelles, A. D., Artigalás, O., da Silva, A. A., Ardila, D. L. V., Alegra, T., Pereira, T. V., Vairo, F. P. e, & Schwartz, I. V. D. (2017). Efficacy and safety of intravenous laronidase for mucopolysaccharidosis type I: A systematic review and meta-analysis. PLoS ONE, 12(8), 1–18. https://doi.org/10.1371/journal.pone.0184065

Chicago

Dornelles, Alícia Dorneles, Osvaldo Artigalás, André Anjos da Silva, Dora Lucia Vallejo Ardila, Taciane Alegra, Tiago Veiga Pereira, Filippo Pinto e Vairo, and Ida Vanessa Doederlein Schwartz. 2017. “Efficacy and Safety of Intravenous Laronidase for Mucopolysaccharidosis Type I: A Systematic Review and Meta-Analysis.” PLoS ONE 12 (8): 1–18. doi:10.1371/journal.pone.0184065.